PKA RIα亚基在心脏收缩力调控与心力衰竭发展中的关键作用
本研究通过心肌细胞特异性敲除RIα的小鼠模型,发现RIα是心脏收缩功能的关键负调控因子。RIα缺失导致基础PKA活性增加约3倍、心肌超收缩及致心律失常性钙波增加,并随年龄增长进展为收缩性心力衰竭,1年死亡率达50%。
要点
- RIα是心脏收缩力、心律失常和病理重塑的关键负调控因子。
- RIα缺失导致心肌超收缩、钙火花频率增加及室性心动过速易感性增加。
- RIα缺失小鼠随年龄增长出现进行性收缩功能障碍、心肌肥厚和纤维化,进展为射血分数降低的心力衰竭。
核心结论
- RIα是心脏收缩功能、心律失常及病理重塑的关键负调控因子。
研究设计与样本
- 研究测量了人类心脏PKA亚基表达,并构建了心肌细胞特异性RIα敲除(RIα-icKO)小鼠模型。
- 通过超声心动图、组织学、ECG和Langendorff灌注心脏评估心肌结构与功能。
- 采用免疫分析法测定PKA活性和cAMP水平,Western blot评估PKA靶点磷酸化。
- 在分离的心室肌细胞中记录L型钙电流、肌节缩短、钙瞬变、钙火花与钙波以及亚细胞cAMP。
主要发现
- 缺血性心肌病所致衰竭人心脏中RIα蛋白减少50%,RIα-icKO小鼠心室和心室肌细胞中减少75%,但心房和窦房结中未减少。
- RIα-icKO小鼠心室肌细胞基础PKA活性增加约3倍。
- 年轻RIα-icKO小鼠左室射血分数增加,普萘洛尔的负性肌力作用被阻止,但心率和普萘洛尔的负性变时作用未改变。
- 普萘洛尔处理的RIα-icKO小鼠中受磷蛋白、兰尼碱受体、肌钙蛋白I和心脏肌球蛋白结合蛋白C的PKA位点磷酸化增加。
- RIα-icKO小鼠心脏呈超收缩状态,心室肌细胞ICa,L、[Ca2+]i瞬变和肌节缩短增加,这些效应可被PKA抑制剂H89抑制。
临床怎么用
- RIα可作为心脏收缩功能和心律失常调控的潜在靶点,但需进一步研究其临床转化价值。
- 心肌细胞特异性RIα缺失导致的心力衰竭模型可用于研究射血分数降低的心力衰竭机制。
局限性
- RIα敲除小鼠存在胚胎致死性,本研究采用条件性敲除模型,可能无法完全反映RIα在胚胎期的心脏功能。
- 研究主要基于小鼠模型,人类心脏中RIα的表达变化仅在缺血性心肌病衰竭心脏中观察到。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The heart expresses 2 main subtypes of cAMP-dependent protein kinase (PKA; type I and II) that differ in their regulatory subunits, RIα and RIIα. Embryonic lethality of RIα knockout mice limits the current understanding of type I PKA function in the myocardium. The objective of this study was to test the role of RIα in adult heart contractility and pathological remodeling. METHODS: We measured PKA subunit expression in human heart and developed a conditional mouse model with cardiomyocyte-specific knockout of RIα (RIα-icKO). Myocardial structure and function were evaluated by echocardiography, histology, and ECG and in Langendorff-perfused hearts. PKA activity and cAMP levels were determined by immunoassay, and phosphorylation of PKA targets was assessed by Western blot. L-type Ca2+ current (ICa,L), sarcomere shortening, Ca2+ transients, Ca2+ sparks and waves, and subcellular cAMP were recorded in isolated ventricular myocytes (VMs). RESULTS: RIα protein was decreased by 50% in failing human heart with ischemic cardiomyopathy and by 75% in the ventricles and in VMs from RIα-icKO mice but not in atria or sinoatrial node. Basal PKA activity was increased ≈3-fold in RIα-icKO VMs. In young RIα-icKO mice, left ventricular ejection fraction was increased and the negative inotropic effect of propranolol was prevented, whereas heart rate and the negative chronotropic effect of propranolol were not modified. Phosphorylation of phospholamban, ryanodine receptor, troponin I, and cardiac myosin-binding protein C at PKA sites was increased in propranolol-treated RIα-icKO mice. Hearts from RIα-icKO mice were hypercontractile, associated with increased ICa,L, and [Ca2+]i transients and sarcomere shortening in VMs. These effects were suppressed by the PKA inhibitor, H89. Global cAMP content was decreased in RIα-icKO hearts, whereas local cAMP at the phospholamban/sarcoplasmic reticulum Ca2+ ATPase complex was unchanged in RIα-icKO VMs. RIα-icKO VMs had an increased frequency of Ca2+ sparks and proarrhythmic Ca2+ waves, and RIα-icKO mice had an increased susceptibility to ventricular tachycardia. On aging, RIα-icKO mice showed progressive contractile dysfunction, cardiac hypertrophy, and fibrosis, culminating in congestive heart failure with reduced ejection fraction that caused 50% mortality at 1 year. CONCLUSIONS: These results identify RIα as a key negative regulator of cardiac contractile function, arrhythmia, and pathological remodeling.
引用
- Bedioune, Gandon-Renard, Dessillons, et al. Essential Role of the RIα Subunit of cAMP-Dependent Protein Kinase in Regulating Cardiac Contractility and Heart Failure Development. Circulation. 2024. PMID: 39355927. doi:10.1161/CIRCULATIONAHA.124.068858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。